Related Experiment Video
Updated: Mar 23, 2026
Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
β-Glucan exacerbates allergic airway responses to house dust mite allergen
Sabelo Hadebe1, Frank Kirstein2, Kaat Fierens3
1Aberdeen Fungal Group, Infection, Immunity and Inflammation Programme, University of Aberdeen, Aberdeen, UK.
Abstract:
β-(1,3)-Glucan is present in mould cell walls and frequently detected in house dust mite (HDM) faeces. β-Glucan exposure is thought to be associated with pulmonary allergic inflammation in mouse and man, although the published data are inconsistent. Here, we show that highly purified β-glucan exacerbates HDM-induced eosinophilic, T helper 2 type airway responses by acting as an adjuvant, promoting activation, proliferation and polarisation of HDM-specific T cells (1-Derβ T cells). We therefore provide definitive evidence that β-glucan can influence allergic pulmonary inflammation.
Insights
Beta-(1,3)-glucan, found in mold and house dust mite (HDM) feces, worsens allergic airway inflammation. This study confirms beta-glucan acts as an adjuvant, amplifying HDM-induced immune responses in the lungs.
Area of Science:
- Immunology
- Allergology
- Pulmonary Medicine
Background:
- Beta-(1,3)-glucan is a component of mold cell walls and is found in house dust mite (HDM) feces.
- Previous studies on the association between beta-glucan exposure and pulmonary allergic inflammation have yielded inconsistent results.
Discussion:
- This research demonstrates that highly purified beta-(1,3)-glucan significantly exacerbates HDM-induced eosinophilic and T helper 2 type airway inflammation.
- Beta-glucan functions as an adjuvant, enhancing the activation, proliferation, and polarization of HDM-specific T cells.
Key Insights:
- Beta-(1,3)-glucan acts as an adjuvant in the context of HDM allergy.
- It promotes the development of T helper 2 (Th2) immune responses.
- The study provides definitive evidence for beta-glucan's role in influencing allergic pulmonary inflammation.
Outlook:
- Further investigation into the precise mechanisms by which beta-glucan modulates immune responses in allergic diseases.
- Exploring potential therapeutic strategies targeting beta-glucan's adjuvant effects in managing allergic asthma.
- Understanding the clinical relevance of beta-glucan exposure in diverse patient populations with respiratory allergies.
Related Concept Videos
02:06Allergic Reactions
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Allergic Reactions: Anaphylaxis
01:29Asthma-I: Introduction
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...